SME Training Event - Online Project Writing Training

  24 August 2020

A record more than 250 companies logged on to our 7th Project Writing Training event for SMEs on 24th August 2020. Our training events are usually staged as face-to-face meetings in various locations across Turkey, but because of on-going international restrictions on travel and public gatherings due to the global pandemic, this event was held on-line. Presentations were given by TUBITAK and key/non experts from the Turkey in Horizon Phase II Project, broadcasting from Turkey, Greece and the UK. The event concluded with an interactive Q&A session.

The organisers were pleased with the popularity of the event and the many questions raised and responded to during over 3 hours of transmission.

2559 TÜBİTAK – MoESTD (Serbia) Bilateral Cooperation Call is Open

  12 August 2020

Within the framework of TÜBİTAK – MoESTD bilateral cooperation call, joint academic research projects between the scientists of the two countries will be supported. This call is open to all thematic areas.

Scientists in Turkey that wants to propose joint research Project proposal to this call, should find a partner from Serbia. Unilateral project applications are not accepted.

This call is open between 10th August 2020 and 9th November 2020. You can find detailed information via using this link: https://uidb-pbs.tubitak.gov.tr

Please clickfor the Call Text.

1ST GENERAL WEBINAR ON H2020 IMI CALL

  27 July 2020

The 1st webinar was dedicated to the IMI-2 Call for proposals. The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of patient access to innovative medicines, particularly in areas where there is an unmet medical or social need. It is facilitated by collaboration between the key players involved in health research, including universities, research centres, pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organizations, and medicines regulators. IMI is the public-private partnership (PPP) in the life sciences. It is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). Through the IMI2 programme, a €3.3 billion budget is being allocated for 2014-2020.

Focus Group Training on MSCA IF

  20 July 2020

A two days of event was organized by TUBITAK on July 16-17, 2020 as on-line training with 47 attendees, under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project which is co-financed by the European Union and the Republic of Turkey and implemented by the Republic of Turkey Ministry of Industry and Technology within the scope of Competitive Sectors of Programme.

In the first day of the training, Dr. Gaye Çetinkaya, MSCA NCP of TÜBİTAK made the opening speech of the training. Dr. Çetinkaya introduced herself and TÜBİTAK International Cooperation Department Horizon 2020 Marie Sklodowska-Curie Actions by mentioning evaluation of proposals with its stages, success rates of the panel proposals, guide for applicants and useful information for the applicants. At the end of her presentation, Dr. Çetinkaya gave information about TÜBİTAK Support Programs, Criteria for the Consultants, MSCA IF Pre-Evaluation Support and Success Awards, Coordinators Support Programme.

Dr Aleksander Bakowski, Team Leader of the Turkey in Horizon 2020 Phase II Project, as taking the floor after Dr Çetinkaya stated overview of MSCA in terms of EU Contribution to Turkish participants, then he presented a brief overview of Turkey in Horizon 2020 Phase II Project by mentioning the upcoming events of the subjected Project.

Mr. Michael Browne, H2020 MSCA IF Trainer, started his thematic training after Dr. Bakowski, Mr. Browned divided the two-days of training into four sessions namely, Excellence, Impact, Implementations and Administrative Requirements. After each session of the training Mr Michael Browne had conducted a Q&A session to evaluate the sessions with the participants.

An Interactive Training

During the training, since interactive session so participants were encouraged to ask questions throughout by raising their hand in the chat function of the video stream or texting question, the participants had to chance ask their question during the training.

See here the presentations during the training.

For all of your questions and/or further information requests, please contact via ncpmobility@tubitak.gov.tr

Eurostars Turkey-Scandinavia Collaboration

  06 July 2020

Denmark, Norway, Sweden and Turkey, actively participating in Eurostars-2, jointly announce a Promotional Call for Project Ideas within the Eurostars-2 Programme. It is to facilitate innovation and technology development in these countries. The call focuses on developing innovative products, processes and services with a strong market potential. Eurostars-2 calls are open for projects within all technology areas.

Please click  here for the call text.

  • You can join the Linkedin Group which is created for this call. In this group you can get in contact with the interested partners and share your ideas.

What is Eurostars?

The Eurostars Programme is a European Joint Programme dedicated to the R&D performing SMEs, and co-funded by the European Commission and 36 EUREKA member countries. Eurostars aims to stimulate these SMEs to lead international collaborative research and innovation projects by easing access to support and funding. It is fine-tuned to focus on the needs of SMEs, and specifically targets the development of new products, processes and services and the access to transnational and international markets. Eurostars projects are collaborative, meaning they must involve at least two participants (legal entities) from two different Eurostars participating countries. In addition, the main participant must be a research-performing SME. Please click here for more information.

TÜBİTAK - JSPS Joint Call Launched!

  09 June 2020

Joint international research projects will be funded within the framework of the bilateral agreement signed between The Scientific and Technological Research Council of Turkey (TÜBİTAK) and Japan Society for Promotion of Science (JSPS) on 4 March 2014.

The applicants who wish to propose joint projects within the framework of TÜBİTAK - JSPS Cooperation Program should find the Japanese/Turkish project partner by themselves. TÜBİTAK and JSPS do not interfere in matching the collaborating partners.

Turkish and Japanese partners shall prepare a joint scientific project. Teams from each country must designate a national scientific coordinator. Projects should be submitted respective funding agencies by each national scientific coordinator. There is no late submission deadline for both Turkish and Japanese teams.  Applicants in Turkey are required to submit their application electronically via http://uidb-pbs.tubitak.gov.tr for the 2544 coded call. The whole process has to be completed by using electronic signature. Japanese project partners are expected to apply to JSPS (please check the application rules of the JSPS: https://www.jsps.go.jp/english/e-bilat/call.html). Unilateral applications will not be taken into evaluation.

TÜBİTAK and JSPS will evaluate the project proposals according to their scientific evaluation criteria. Both organizations will exchange their scientific evaluation results, and only the overlapping projects that are found acceptable for both parties will be funded. Two (2) projects will be funded under this call.

Only the research projects will be funded under this call. The projects will be implemented through the exchange of researcher and knowledge. Based on the respective bilateral agreement between TÜBİTAK and JSPS, each party will cover the costs of their own national team. While submitting the project proposal form, the costs which are requested in the scope of the project must be stated in detail and justified. In the case of any exchange of researcher to be made within the scope of the projects, the sending party meets all related costs connected with travel, lodging and allowances according to their own regulations and allowances. The provisions of per diem Law No. 6245 will be applied for the Turkish team during their scientific visits from Turkey to Japan. TÜBİTAK will fund Turkish side under the financial principles of TÜBİTAK 1071 Program (please check the application rules for Turkish side, https://www.tubitak.gov.tr/sites/default/files/3125/1071_arastirma_projeleri_surec_dokumani.pdf). 

Please click here for the call text.

ICT 2020 - Save the Date!

  22 May 2020

The European Commission, together with the German Presidency and the Federal Ministry of Education and Research, is proud to bring you "ICT 2020: Leading the Digital Age", taking place in Cologne, Germany.

It is hard to overstate the growing impact of data and digital technologies on everyday life of European citizens, governments, public authorities and industry.

The global coronavirus pandemic and the resulting public health emergency affected the whole of Europe. While preparing an adequate response to the economic impact and social consequences, Europe was able to count heavily on digital technologies, infrastructures and know-how to ensure business continuity.

In a time of reconstruction, the next decade should witness a Europe that strives for more prosperity building on its excellence in science and technology, at the forefront of innovation.

Europe will set the rhythm of global sustainable development, fighting climate change, underpinning transformation towards carbon-neutral industrial processes, preserving our planet’s ecosystems and offering opportunities to all.

This can only be realised if Europe takes a leading role in shaping the digital age. The European digital strategy will foster technological choice and industrial competitiveness across sectors to deliver the positive impacts to society.

Making Europe and Europeans “fit for the digital age” is a key policy priority for the new Commission. For that to happen Europe must invest in the creation of knowledge and its deployment stimulating innovation across domains.

At the start of a new EU MFF (2021-2027), ICT 2020 will present collaboration opportunities offered by Horizon Europe (HE) and the Digital Europe Programme (DEP).

ICT 2020 will host a high-level policy conference, an interactive exhibition of EU-funded projects in the field of ICT, numerous networking opportunities and much more! It is a unique occasion to bring together 5 000 researchers, innovators and engineers from all ICT fields, policy and business decision makers, as well as investors and venture capitalists.

 

For more information about TÜBİTAK Ufuk2020 Travel Support please click here.

EC Response to Coronavirus

  20 April 2020

European Commission responded to COVID-19 pandemic with a number of initiatives. The most important of these are summarised below. However, you can check the European Research Area (ERA) corona platform for information on related research & innovation!

H2020

An emergency call “SC1-PHE-CORONAVIRUS-2020: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic” was announced on Jan 30, 2020. Original budget for this call was 10m which was subsequently increased up to €48.5 million. CALL LINK.

This call was closed on Feb 2020 and results came out on March 6. Initially 17 projects were selected and one more was added late March. See here and Attachment for the list of projects.

This was a very specific and targeted call mainly to scientific teams that had already been working in solutions. There were no Turkish institutions in this first call.

IMI

In addition to the above, the Innovative Medicines Initiative (IMI), a public-private partnership between the European Commission and the pharmaceutical industry, has launched a fast-track call for research proposals to develop treatments and diagnostics in response to the COVID-19 outbreak.

IMI2 – Call 20 was dedicated to Covid-19: Development of therapeutics and diagnostics combatting coronavirus infections. This call opened on Mar 3 and closed on Mar 31. Fast Track Procedure. 144 proposals submitted.

There are 4 more IMI2 Open calls that are relevant to Health and medicine community. Although not explicitly dedicated to Covid-19 they do cover main aspects like digital health information, vaccine acceleration and more (All open calls of IMI2 are here).

EIC

The European Innovation Council (EIC) explicitly made a mention to urge SMEs work on COVID-19 actions (here). More than 4000 proposals were received with 1000 of them on COVID-19 actions.

This round closed on Mar 20, but call is recurrent so there will be next opportunities in Jun and Nov. (See here)

OTHER INITIATIVES

There are also plenty of other initiatives announced almost every day. These initiatives come from projects/consortia that have already received funding and call for further collaboration or sub-grants (Cascading funding). For instance: Exscalate4CoV (E4C) invites collaboration to screen potential drugs, or this initiative from Robotic Alliance (Here).

Last but not least, almost all call deadlines were extended. See all these extensions here.